10.04.2024 – 11:00Dr. Reddy's Laboratories SADr. Reddy's subsidiary betapharm, and Theranica launch Nerivio® in Germany to provide patients with drug-free migraine treatmentmore
02.04.2024 – 11:10Helmholtz MunichScientists Reveal Adipocyte's Metabolic Role and Identify Treatment Targetsmore
14.03.2024 – 07:31STADA Arzneimittel AGPress release: STADA continues with double-digit sales and profit growth in 2023One documentmore
13.03.2024 – 16:21FDX Fluid Dynamix GmbH4FDX Fluid Dynamix and Fraunhofer IPK to Collaborate with Lonza on Novel Nanoparticle Formulation Technology Platform FDmiXmore
28.02.2024 – 15:00RHEACELL GmbH und Co. KGResearch Success in Rare Disease / RHEACELL receives positive signal for accelerated stem cell development program in rare ‚Butterfly Disease‘more
28.02.2024 – 11:07Helmholtz MunichRising Focus on 'Inceptor' as a Type 2 Diabetes Therapeutic Targetmore
23.02.2024 – 10:28Leipzig Tourismus und Marketing GmbH5Pioneering Heart Surgery and Medical Congresses in LeipzigOne documentmore
22.02.2024 – 13:23Helmholtz MunichTherapeutic Vaccine for Chronic Hepatitis B Enters Clinical TrialMore information on the therapeutic vaccine TherVacBmore
19.02.2024 – 17:05Helmholtz MunichWhat Our Genetic Information Tells Us About Type 2 Diabetes Risk and ComplicationsLearn more about research at Helmholtz Munichmore
01.02.2024 – 10:02Sysmex Europe SEStrengthening the Direct Sales and Service System for Business Expansion in ItalyVisit our website!One documentmore
26.01.2024 – 13:50Biomay AGBiomay Announces its Successful Support of Approval of First CRISPR/Cas9-based Therapymore
06.12.2023 – 16:00LTS Lohmann Therapie-Systeme AGLTS receives grant of $1.2 Million to support the development of thermostable mRNA formulations for Microneedle Array Patchesmore
16.11.2023 – 10:27Fruit Vegetables EuropeTen benefits of a daily intake of citrus fruits during winter seasonmore
31.10.2023 – 10:00ARTTIC Innovation GmbH2PIONEER+ becomes Big Data Platform for Prostate Cancer of the EAU's UroEvidenceHubPIONEER Videomore
12.10.2023 – 14:01ARTTIC Innovation GmbH3EU Provides 1 Mio. to Researchers to Advance Personalised OncologycanSERV CallOne documentmore
12.10.2023 – 14:00ARTTIC Innovation GmbHcanSERV Releases Open Call for Transnational Service ProvisioncanSERV CallOne documentmore
02.10.2023 – 17:06Helmholtz MunichDeepMB: A Deep Learning Framework For High-Quality Optoacoustic Imaging in Real-Timemore
30.08.2023 – 12:28STADA Arzneimittel AG2Press release : People with Parkinson’s experience variations in effects of oral medicines, but lack advice, international survey revealsOne documentmore
15.08.2023 – 07:01STADA Arzneimittel AG2Press release: STADA's excellent results in H1 2023 indicate a record annual profit of €1 bn, driven by Consumer Healthcare and SpecialtyOne documentmore
08.08.2023 – 08:00ARTTIC Innovation GmbH4PIONEER Big Data in Prostate Cancer Platform Opens up to Asian Data SetsMore about PIONEERmore
05.07.2023 – 17:15Helmholtz MunichPotentiating Cancer Vulnerability to Ferroptosis: Off-Targeting Effects of DHODH Inhibitorsmore
30.06.2023 – 10:09ARTTIC Innovation GmbH2CARAMBA: New Hope for Multiple Myeloma PatientsCARAMBA project websitemore
28.06.2023 – 17:13Helmholtz MunichNew Approach in Cancer Therapy With Innovative Mechanism-of-Action for Ferroptosis Inductionmore
27.06.2023 – 11:23RHEACELL GmbH und Co. KGRHEACELL announces “First Patient In”: EB-Haus in Salzburg, Austria starts pivotal study for stem cell therapy for severe forms of Epidermolysis bullosa that is longed for by those affectedmore